Mono- and combinational drug therapies for global viral pandemic preparedness

Broadly effective antiviral therapies must be developed to be ready for clinical trials, which should begin soon after the emergence of new life-threatening viruses. Here, we pave the way towards this goal by reviewing conserved druggable virus-host interactions, mechanisms of action, immunomodulato...

Descripción completa

Detalles Bibliográficos
Autores principales: Ianevski, Aleksandr, Yao, Rouan, Simonsen, Ronja M., Myhre, Vegard, Ravlo, Erlend, Kaynova, Gerda D., Zusinaite, Eva, White, Judith M., Polyak, Stephen J., Oksenych, Valentyn, Windisch, Marc P., Pan, Qiuwei, Lastauskienė, Eglė, Vitkauskienė, Astra, Matukevičius, Algimantas, Tenson, Tanel, Bjørås, Magnar, Kainov, Denis E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983340/
https://www.ncbi.nlm.nih.gov/pubmed/35402870
http://dx.doi.org/10.1016/j.isci.2022.104112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983340/
https://www.ncbi.nlm.nih.gov/pubmed/35402870
http://dx.doi.org/10.1016/j.isci.2022.104112

Ejemplares similares